Bruce Barton to Wharton Jelly
This is a "connection" page, showing publications Bruce Barton has written about Wharton Jelly.
Connection Strength
0.226
-
Yang VK, Meola DM, Davis A, Barton B, Hoffman AM. Intravenous administration of allogeneic Wharton jelly-derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease. Am J Vet Res. 2021 Jun; 82(6):487-493.
Score: 0.186
-
Crain SK, Robinson SR, Thane KE, Davis AM, Meola DM, Barton BA, Yang VK, Hoffman AM. Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model. Stem Cells Dev. 2019 02 01; 28(3):212-226.
Score: 0.040